|
Daily Medical Update
Pseudogout
Wednesday, July 08, 2026
|
🔬 Practice-Changing Findings
Evidence from RCTs and meta-analyses published in the
last 12 months.
|
Modern Rheumatology (2026) - Meta-Analysis
Key Findings
- Across 6 studies with 84 patients, anakinra produced a pooled positive treatment response rate of 76% between day 3 and day 5 (95% CI 61-86).
- Pooled outcomes showed a 48.12 mm reduction in pain VAS and a 62.09 mg/L reduction in CRP from baseline, with reported adverse events including injection-site reactions, rash, bacterial pneumonitis, and neutropenia.
📋 Practice Implication: Consider anakinra for acute pseudogout when NSAIDs, colchicine, or glucocorticoids are limited by comorbidity, while monitoring for infectious and hematologic adverse effects.
|
Arthritis Care & Research (2025) - Randomized Controlled Trial Post Hoc Analysis
Key Findings
- Only 43 of 89 participants (48.3%) achieved definite day-3 response, showing that early complete flare resolution remained difficult with either colchicine or prednisone.
- Wrist involvement was associated with better day-3 resolution (odds ratio 4.06), whereas randomization to colchicine (odds ratio 0.31) and diuretic use (odds ratio 0.23) were associated with poorer response.
📋 Practice Implication: Prednisone may be the more reliable first choice for acute pseudogout in patients taking diuretics or at higher gastrointestinal risk, rather than defaulting to colchicine.
|
Skeletal Radiology (2025) - Cross-Sectional Study
Key Findings
- Among participants with knee osteoarthritis, 19 of 158 with pain data (12%) and 13 of 115 with MRI data (11.3%) had intra-articular calcium crystal deposits on CT.
- Calcium crystal deposits were not associated with worse KOOS pain scores (mean difference -2.2 points, 95% CI -10.86 to 6.45) or with MRI markers of joint inflammation.
📋 Practice Implication: Do not assume incidental chondrocalcinosis or CT-detected calcium crystals are the main driver of knee pain in osteoarthritis without corroborating inflammatory features.
|
Archives of Orthopaedic and Trauma Surgery (2025) - Case Series
Key Findings
- In 8 patients with intraoperative white deposits, 6 cases (75%) were confirmed to contain CPPD crystals on pathologic assessment.
- Only 1 of the 6 CPPD-positive patients (16.7%) had a pre-existing pseudogout diagnosis, despite grossly similar-appearing white material across cases.
📋 Practice Implication: Unexpected white material seen during arthroplasty or other joint surgery should be sent for pathology before it is labeled infection, debris, or steroid residue.
|
Cureus (2025) - Case Report
Key Findings
- An immunosuppressed 67-year-old man with rheumatoid arthritis presented with leukocytosis, elevated CRP and ESR, mildly increased procalcitonin, and wrist effusion that initially prompted empiric vancomycin for presumed septic arthritis.
- Synovial microscopy showed numerous rhomboid weakly positively birefringent crystals, cultures were negative, and the patient improved rapidly after antibiotics were stopped and corticosteroids were given.
📋 Practice Implication: When pseudogout and septic arthritis both seem plausible, early arthrocentesis with crystal analysis can narrow treatment faster and reduce unnecessary antibiotic exposure.
|
|
💡
Summary
Recent pseudogout literature remains centered on acute CPP crystal arthritis treatment and on avoiding diagnostic misclassification rather than on disease-modifying therapy. The strongest higher-significance studies support anakinra as an option for selected acute flares, suggest prednisone may outperform colchicine in some subgroups with less gastrointestinal burden, and show that CPPD still commonly mimics infection or postoperative pathology. A negative osteoarthritis imaging study also cautions against assuming incidental calcium crystal deposition alone explains knee pain or synovitis.
|
|